Changing paradigms in oral anticoagulation during cardioversion in Europe
Eur Heart J Cardiovasc Pharmacother
.
2018 Jan 1;4(1):2-3.
doi: 10.1093/ehjcvp/pvx025.
Authors
Patrick Sulzgruber
1
2
,
Alexander Niessner
1
Affiliations
1
Department of Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
2
Ludwig Boltzmann Institute, Cluster for Cardiovascular Research, Vienna, Austria.
PMID:
29036281
DOI:
10.1093/ehjcvp/pvx025
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants*
Atrial Fibrillation
Electric Countershock*
Europe
Humans
Thromboembolism
Substances
Anticoagulants